Legend Biotech (LEGN) Revenue & Revenue Breakdown
Legend Biotech Revenue Highlights
Latest Revenue (Y)
$285.14M
Latest Revenue (Q)
$93.99M
Main Segment (Y)
Joint Steering Committee Service
Main Geography (Y)
UNITED STATES
Legend Biotech Revenue by Period
Legend Biotech Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $285.14M | 143.70% |
2022-12-31 | $117.00M | 30.31% |
2021-12-31 | $89.79M | 18.65% |
2020-12-31 | $75.68M | 32.15% |
2019-12-31 | $57.26M | 16.55% |
2018-12-31 | $49.13M | - |
Legend Biotech Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $93.99M | 18.28% |
2023-12-31 | $79.46M | -17.24% |
2023-09-30 | $96.01M | 30.93% |
2023-06-30 | $73.33M | 101.81% |
2023-03-31 | $36.34M | 31.49% |
2022-12-31 | $27.63M | 0.99% |
2022-09-30 | $27.36M | 128.56% |
2022-06-30 | $11.97M | -70.68% |
2022-03-31 | $40.83M | 4.70% |
2021-12-31 | $38.99M | 130.99% |
2021-09-30 | $16.88M | -16.56% |
2021-06-30 | $20.23M | 47.88% |
2021-03-31 | $13.68M | -66.45% |
2020-12-31 | $40.78M | 247.18% |
2020-09-30 | $11.75M | 1.27% |
2020-06-30 | $11.60M | 0.47% |
2020-03-31 | $11.55M | -40.64% |
2019-12-31 | $19.45M | 10.05% |
2019-09-30 | $17.67M | 75.22% |
2019-06-30 | $10.09M | 0.34% |
2019-03-31 | $10.05M | - |
Legend Biotech Revenue Breakdown
Legend Biotech Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 21 | Dec 20 |
---|---|---|
Joint Steering Committee Service | $54.52M | $46.78M |
Licensing Of Intellectual Property | $4.91M | $5.63M |
Latest
Legend Biotech Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|
UNITED STATES | $234.73M | $116.60M | $86.37M | - |
Europe | $15.07M | - | - | - |
CHINA | $179.00K | $328.00K | $3.42M | - |
Other Countries | - | $75.00K | - | - |
North America | - | - | - | $75.68M |
Latest
Legend Biotech Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals | $1.83B | $420.15M |
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
APLS | Apellis Pharmaceuticals | $366.28M | $176.57M |
LEGN | Legend Biotech | $285.14M | $93.99M |
ZLAB | Zai Lab | $266.72M | $100.50M |
ASND | Ascendis Pharma | $266.72M | $95.89M |
BPMC | Blueprint Medicines | $249.38M | $128.18M |
TVTX | Travere Therapeutics | $145.24M | $62.90M |
ACLX | Arcellx | $110.32M | $26.03M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
PLRX | Pliant Therapeutics | $1.58M | - |
PCVX | Vaxcyte | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
TERN | Terns Pharmaceuticals | - | - |
ETNB | 89bio | - | - |
AKRO | Akero Therapeutics | - | - |